PROVIDENCE – Rhode Island will share $40.75 million with 37 other states as part of a settlement with GlaxoSmithkline LLC and SB Pharmco Puerto Rico Inc. from alleged substandard manufacturing processes.
Rhode Island’s portion is $564,503, R.I. Attorney General Peter F. Kilmartin said on Thursday, noting that the settlement is subject to final approval by the Superior Court.
Along with the settlement, Kilmartin filed a complaint Thursday alleging that the two entities engaged in unfair and deceptive practices by manufacturing and distributing certain lots of drugs that were adulterated due to substandard manufacturing processes.
Those lots of drugs included Kytril, a sterile drug used to prevent nausea and vomiting caused by cancer chemotherapy and radiation therapy; Bactroban, an antibiotic ointment used to treat skin infections; Paxil CR, the controlled release formulation of the popular antidepressant drug; and Advandamet, a combination Type II diabetes drug.
The settlement predicated on SB Pharmco’s admission of the federal criminal information which was settled in October 2010; the settlement – between GSK and the U.S. Department of Justice – included a criminal fine and forfeiture totaling $150 million and a $600 million civil settlement under the False Claims Act and related state claims. Rhode Island received $588,000 for the state’s Medicaid program in addition to Thursday’s amount.
The attorney general noted that consumers should not currently be concerned about the drugs because all adulterated batches have been recalled.
“The public trusts that the prescription drugs they take for serious medical problems are safe and manufactured according to the highest standards,” said Kilmartin. “With the record profits the pharmaceutical companies make, it is egregious they would cut corners and put millions of people at risk.”
The Rhode Island attorney general’s office may retain some of the settlement to cover expenses associated with the case and other administrative costs – up to $65,000 per fiscal year for all of the cases covered – and the rest will go to the state’s general fund.
No posts to display
- Featured Event -
Glaxo whistle-blower gets $96 million.
The case with the Zyprexa scandal is that Eli Lilly drug company pleaded guilty to criminal wrongs (*viva Zyprexa* campaign) the Zyprexa saga was rotten through and through.
Eight Lilly EMPLOYEES got millions each as supposed informant ‘whistle blowers’.Lawyers on BOTH sides got millions and millions……most patient claimants who got sick are ‘mentally challenged’ and less able to advocate for themselves.
The Class action Lawsuits in the US had payouts of $85,000 BUT the lawyers got 45 percent and then the govt got most of the rest for having to take care of the victim/patients medical expenses.Soooo,,,,$85K turned into about $9,000 for Zyprexa claimants many had their food stamps and other state benefits taken away because of their *windfall profit* making them worse off in the end.
*
Daniel Haszard Zyprexa victim activist and patient who got diabetes from it. http://www.zyprexa-victims.com
(Only 9 percent of adult Americans think the pharmaceutical industry can be trusted right around the same rating as big tobacco.)